Telix Acquires RLS to Expand North American Manufacturing and Distribution Platform

MELBOURNE, Australia and INDIANAPOLIS, Ind. and LAKE MARY, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS, RLS Radiopharmacies), America’s only Joint Commission-accredited radiopharmacy network that distributes PET medicines¹SPECT² and therapeutic radiopharmaceuticals, today announced an agreement by the company to acquire RLS from its parent company, RLS Group Ltd. The acquisition significantly expands Telix’s North American manufacturing footprint and lays the foundation for a next-generation radiometal production network serving Telix and select strategic commercial partners.

Strategic reasoning